Cargando…
Early prediction of COVID‐19 severity using extracellular vesicle COPB2
The clinical manifestations of COVID‐19 vary broadly, ranging from asymptomatic infection to acute respiratory failure and death. But the predictive biomarkers for characterizing the variability are still lacking. Since emerging evidence indicates that extracellular vesicles (EVs) and extracellular...
Autores principales: | Fujita, Yu, Hoshina, Tokio, Matsuzaki, Juntaro, Yoshioka, Yusuke, Kadota, Tsukasa, Hosaka, Yusuke, Fujimoto, Shota, Kawamoto, Hironori, Watanabe, Naoaki, Sawaki, Kenji, Sakamoto, Yohei, Miyajima, Makiko, Lee, Kwangyole, Nakaharai, Kazuhiko, Horino, Tetsuya, Nakagawa, Ryo, Araya, Jun, Miyato, Mitsuru, Yoshida, Masaki, Kuwano, Kazuyoshi, Ochiya, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172627/ https://www.ncbi.nlm.nih.gov/pubmed/34122778 http://dx.doi.org/10.1002/jev2.12092 |
Ejemplares similares
-
Extracellular Vesicles in Chronic Obstructive Pulmonary Disease
por: Kadota, Tsukasa, et al.
Publicado: (2016) -
1069. Predictive Factors for Metastatic Infection in Patients With Bacteremia Caused by Staphylococcus aureus
por: Shimizu, Akihiro, et al.
Publicado: (2018) -
Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo
por: Sakamoto, Yohei, et al.
Publicado: (2022) -
Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalk
por: Kadota, Tsukasa, et al.
Publicado: (2021) -
Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesis
por: Fujita, Yu, et al.
Publicado: (2015)